-+ 0.00%
-+ 0.00%
-+ 0.00%

Tevogen Bio Announces $9-11 Billion Valuation for TVGN-489, Highlighting Promising Phase I Clinical Trial Results for COVID-19 Treatment

Reuters·09/08/2025 13:27:59

Please log in to view news